eLetters

55 e-Letters

published between 2009 and 2012

  • Some errors in data extraction
    Hsin-Chun Lee
    Dear Editor: I would like to spot two obvious errors at the data extraction in the article by Kalichman et al on the systematic review of the prevalence of sexually transmitted coinfections in people living with HIV/AIDS. First, in Table 1 the study site of the Reference 31 by our study group, was located in Taiwan, instead of China. Second, it is clearly listed in the text of the Reference 31 that 79.7% of the participants had r...
    Show More
  • Sexual health in general practice: missing those at highest risk?
    Craig Tipple

    Madam, We read with interest a recent article comparing the expectations and experiences of STI care in general practice(1). The need for appropriate sexual health services in primary care is clear especially when recent data show the prevalence of HIV-1 to have reached 2 per 1000 in 37 primary care trusts (PCTs) in England(2). Patients interviewed in the study by Sutcliffe et al had initially presented to general pract...

    Show More
  • Moving forward with technology
    Dornubari Blythin

    E-learning is the modern way of delivering the information required for the induction programme at many NHS hospitals.

    As a junior doctor who has undergone multiple inductions at different hospital sites and into different specialties, I have found that the training tracker was always a much better method of delivering induction material. Having experienced lecture based inductions, which usually end up with a l...

    Show More
  • Determine HIV-1/2 /Ab/Ag Combo lacks sensitivity in detecting early HIV infections
    Erasmus Smit

    Dear Editor

    Fox, Dunn and O'Shea stressed the importance of diagnosing primary HIV infecting (PHI) to prevent onward transmission and help control the HIV epidemic1. They evaluated the 4th generation HIV-1/2 Ag/Ag Determine Combo assay (Alere) for its ability to detect p24 antigen as a marker of PHI and have shown its poor sensitivity in detecting PHI and recommended further evaluations of the assay. Many pati...

    Show More
  • What are the confounding variables?
    John D Dalton

    It is impossible to judge the validity of this finding without data on the confounding variables.

    Given the Indian setting it seems likely that those who are circumcised are Muslims whereas those who are not will be mostly Hindus. As such the circumcised participants are subject to a different sexual mores giving doubt to the conclusion.

    Circumcision has long been advocated on the basis of simplistic...

    Show More
  • Brief Encounters-Helen Ward
    Claire Hummins

    Hi, I am interested in the article which was published in 2008 called Brief Encounters by Helen Ward and Emma Meader which concerns Chlamydia and Toilet seats.

    http://sti.bmj.com:80/cgi/content/full/84/2/107

    Does this mean that it IS possible to catch an STI from a surface and that they can survive on surfaces for up to 50 days and within that 50 remain active enough to be caught? I am not just talking about c...
    Show More
  • Re: Urological Management of Epididymo-Orchitis; Simple, Ofloxacin for all!
    Colm O`Mahony

    The letter by Philips et al1 about urological management of acute epididymo-orchitis reflects the experience of all of us who pick up the pieces after mis-management of epididymo-orchitis. However, before we can criticise our Urology colleagues we really have to look at our guidelines and see how useful they are? The BASHH Guideline for Management of Epididymo-Orchitis2 is largely aimed at level 3 services that have ins...

    Show More
  • Decline in genital warts in Melbourne: How much is really due to the implementation of the Australian national quadrivalent human papillomavirus vaccination programme?
    Marie-Claude Boily

    We read the article by Fairley et al(1) with great interest. The authors concluded that the decline in genital warts among women in the age groups (<28 years) targeted for vaccination provides strong evidence for the population-level effectiveness of the vaccine. They also report that this conclusion was strengthened by the fact that no significant decline in genital warts post vaccination has been noted among other ri...

    Show More
  • Re:Pharyngeal and Rectal Testing for Chlamydia trachomatis in MSM: Evidence Base
    Peter Watson

    I thank Dr Alexander for her reply. However I question the assumption that Chlamydia trachomatis is always a pathogen, wherever it is found. Before we embark on what could be a costly programme of screening for C. trachomatis in the throat and the rectum, do we not need some evidence that the detection and treatment of asymptomatic infection in those sites will be associated with clinical benefit in the patients and th...

    Show More
  • Time to improve HIV testing and recording of HIV diagnosis in UK primary care - a response
    Surinder Singh

    Richard Ma makes some excellent points in his editorial (1). I would like to 'correct' a misperception but add to the current debate about HIV-testing and subsequent care within UK general practice. Ma states that it was the use of highly active antiretroviral therapy (HAART) which precipitated the debates around shared care of patients with HIV infection. Unfortunately this is not true. For those old enough to remember,...

    Show More

Pages